These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18821520)

  • 21. Evaluation of lung function and deposition of aerosolized bronchodilators carried by heliox associated with positive expiratory pressure in stable asthmatics: a randomized clinical trial.
    Alcoforado L; Brandão S; Rattes C; Brandão D; Lima V; Ferreira Lima G; Fink JB; Dornelas de Andrade A
    Respir Med; 2013 Aug; 107(8):1178-85. PubMed ID: 23664767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA; Donohue JF
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Longitudinal growth in children with asthma treated with inhaled glucocorticoids].
    Gradman J; Wolthers OD
    Ugeskr Laeger; 2006 Feb; 168(9):885-9. PubMed ID: 16513049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study.
    Sharafkhaneh A; Southard JG; Goldman M; Uryniak T; Martin UJ
    Respir Med; 2012 Feb; 106(2):257-68. PubMed ID: 22033040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asthma.
    Cates C; FitzGerald JM
    Clin Evid; 2002 Jun; (7):1325-43. PubMed ID: 12230750
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of long-acting bronchodilators in COPD patients according to COPD severity and ICS use.
    Decramer M; Dahl R; Kornmann O; Korn S; Lawrence D; McBryan D
    Respir Med; 2013 Feb; 107(2):223-32. PubMed ID: 23219347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chronic obstructive pulmonary disease (COPD): diagnosis and treatment].
    Kardos P
    Dtsch Med Wochenschr; 2004 Mar; 129(10):490-3. PubMed ID: 14986237
    [No Abstract]   [Full Text] [Related]  

  • 28. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
    Bölükbas S; Eberlein M; Eckhoff J; Schirren J
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):995-1000. PubMed ID: 20970351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bronchodilator reversibility in chronic obstructive pulmonary disease: use and limitations.
    Calverley PM; Albert P; Walker PP
    Lancet Respir Med; 2013 Sep; 1(7):564-73. PubMed ID: 24461617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up after two years of asthma treatment guided by airway responsiveness in children.
    Nuijsink M; Vaessen-Verberne AA; Hop WC; Sterk PJ; Duiverman EJ; de Jongste JC;
    Respir Med; 2013 Jul; 107(7):981-6. PubMed ID: 23672993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is there any association between inhaled ipratropium and mortality in patients with COPD and asthma?
    Ringbaek T; Viskum K
    Respir Med; 2003 Mar; 97(3):264-72. PubMed ID: 12645834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study.
    Bateman ED; Boushey HA; Bousquet J; Busse WW; Clark TJ; Pauwels RA; Pedersen SE;
    Am J Respir Crit Care Med; 2004 Oct; 170(8):836-44. PubMed ID: 15256389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How much is too much? The treatment of mild asthma.
    O'Byrne PM
    Eur Respir J; 2007 Sep; 30(3):403-6. PubMed ID: 17766628
    [No Abstract]   [Full Text] [Related]  

  • 35. Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD.
    Schermer TR; Albers JM; Verblackt HW; Costongs RJ; Westers P
    Fam Pract; 2007 Apr; 24(2):181-8. PubMed ID: 17251178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra-long-acting β₂-adrenoceptor agonist, with formoterol in patients with asthma.
    Bjermer L; Rosenborg J; Bengtsson T; Lötvall J
    Ther Adv Respir Dis; 2013 Oct; 7(5):264-71. PubMed ID: 23907810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
    Siva R; Green RH; Brightling CE; Shelley M; Hargadon B; McKenna S; Monteiro W; Berry M; Parker D; Wardlaw AJ; Pavord ID
    Eur Respir J; 2007 May; 29(5):906-13. PubMed ID: 17301099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
    Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
    N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doubling daily inhaled corticosteroid dose is ineffective in mild to moderately severe attacks of asthma in adults.
    Rice-McDonald G; Bowler S; Staines G; Mitchell C
    Intern Med J; 2005 Dec; 35(12):693-8. PubMed ID: 16313543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials.
    Dransfield MT; Bourbeau J; Jones PW; Hanania NA; Mahler DA; Vestbo J; Wachtel A; Martinez FJ; Barnhart F; Sanford L; Lettis S; Crim C; Calverley PM
    Lancet Respir Med; 2013 May; 1(3):210-23. PubMed ID: 24429127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.